DrugPatentWatch Database Preview
Degarelix acetate - Generic Drug Details
» See Plans and Pricing
What are the generic sources for degarelix acetate and what is the scope of freedom to operate?
Degarelix acetate
is the generic ingredient in one branded drug marketed by Ferring and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Degarelix acetate has one hundred and forty patent family members in thirty-six countries.
One supplier is listed for this compound.
Summary for degarelix acetate
International Patents: | 140 |
US Patents: | 5 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Clinical Trials: | 30 |
Patent Applications: | 4,614 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for degarelix acetate |
DailyMed Link: | degarelix acetate at DailyMed |
Recent Clinical Trials for degarelix acetate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
City of Hope Medical Center | Phase 2 |
NRG Oncology | Phase 3 |
Alliance for Clinical Trials in Oncology | Phase 3 |
Paragraph IV (Patent) Challenges for DEGARELIX ACETATE
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
FIRMAGON | POWDER;SUBCUTANEOUS | degarelix acetate | 022201 | 2019-12-20 |
US Patents and Regulatory Information for degarelix acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | Get Started Free | Get Started Free | Get Started Free | ||||
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | Get Started Free | Get Started Free | Get Started Free | ||||
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | Get Started Free | Get Started Free | Y | Y | Get Started Free | ||
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | Get Started Free | Get Started Free | Get Started Free | ||||
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | Get Started Free | Get Started Free | Get Started Free | ||||
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | Get Started Free | Get Started Free | Get Started Free | ||||
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | Get Started Free | Get Started Free | Get Started Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for degarelix acetate
Country | Patent Number | Estimated Expiration |
---|---|---|
Israel | 132303 | Get Started Free |
Eurasian Patent Organization | 020543 | Get Started Free |
Mexico | 2010008816 | Get Started Free |
Japan | 2019218360 | Get Started Free |
China | 1230442 | Get Started Free |
Czech Republic | 9903586 | Get Started Free |
South Korea | 101542480 | Get Started Free |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for degarelix acetate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1003774 | SPC020/2009 | Ireland | Get Started Free | SPC020/2009: 20091119, EXPIRES: 20230412 |
1003774 | 09C0028 | France | Get Started Free | PRODUCT NAME: DEGARELIX, SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, EN PARTICULIER ACETATE; REGISTRATION NO/DATE IN FRANCE: EU/1/08/504/001 DU 20090217; REGISTRATION NO/DATE AT EEC: EU/1/08/504/001 DU 20090217 |
1003774 | 122009000033 | Germany | Get Started Free | PRODUCT NAME: DEGARELIX, GGF. IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES DAVON, WIE DEM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001-002 20090217 |
1003774 | PA2009005,C1003774 | Lithuania | Get Started Free | PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217 |
1003774 | 91585 | Luxembourg | Get Started Free | PRODUCT NAME: DEGARELIX, EVENTUELLEMENT UN SEL PHARMACEUTIQUEMENT ACCEPTABE, TEL QUE L'ACETATE (FIRMAGON); REG. DATE: 20090217 |
1003774 | PA2009005 | Lithuania | Get Started Free | PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217 |
1003774 | SPC/GB09/028 | United Kingdom | Get Started Free | PRODUCT NAME: DEGARELIX OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT SUCH AS THE ACETATE; REGISTERED: UK EU/1/08/504/001 20090217; UK EU/1/08/504/002 20090217 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |